4 papers in the library · 142 citations · publishing 2012-2015
Human Psychopharmacology: Clinical and Experimental July 1, 2015 Lynn T. Singer, Derek G. Moore, Meeyoung O. Min et al. 16 citations
This paper aims to review findings from a longitudinal study of prenatal methylenedioxymethamphetamine (MDMA, “ecstasy”) on infant development.
Journal of Psychopharmacology January 2014 John Turner, Andrew C. Parrott, Julia Goodwin et al.
The recreational drug MDMA (3,4-methylenedioxymethamphetamine) or 'Ecstasy' is associated with heightened psychiatric distress and feelings of depression. The Drugs and Infancy Study (DAISY) monitored the psychiatric symptom profiles of mothers who used Ecstasy/MDMA while pregnant, and followed them over the first year post-partum. We compared 28 young women whom took MDMA during their...
Pediatrics August 21, 2012 Lynn T. Singer, David G. Moore, Meeyoung O. Min et al. 49 citations
OBJECTIVE: A widely used illicit recreational drug among young adults, 3,4-methylenedioxymethamphetamine (MDMA) or ecstasy, is an indirect monoaminergic agonist/reuptake inhibitor affecting the serotonin system. Preclinical studies found prenatal exposure related to long-term learning and memory impairments. There are no studies of sequelae of prenatal MDMA exposure in humans, despite potential...
Neurotoxicology and Teratology March 5, 2012 Lynn T. Singer, David G. Moore, Sarah Fulton et al. 77 citations
3,4-methylenedioxymethamphetamine (MDMA) or "Ecstasy" is one of the most widely used illicit recreational drugs among young adults. MDMA is an indirect monoaminergic agonist and reuptake inhibitor that primarily affects the serotonin system. Preclinical studies in animals have found prenatal exposure related to neonatal tremors and long-term learning and memory impairments. To date, there are...